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Estimated age (SD): mean age from SRBC was 29.9-yr (±6.8)
vs. CVM 35.5-yr (±9.2) (p= 0.0006).
Frequency analysis showed a greater proportion of shoulder and
thoracic spine OA in CVM population (44% vs. 19.1% [p<0.009]
and 36% vs. 6,8% [p=0.04], respectively). However, in SRBC
population knee OA was more prevalent (67.4% vs. 52.5%
[p<0.03]).
A gender sub-analysis showed a greater proportion of male knee
(68%) and lumbar spine (55%) OA vs. female 48% (p=0.016)
and 46% (p<0.032), respectively. However, female displayed a
greater proportion of elbow OA (46% vs. 33.8% [p<0.033]).
Male agriculturalists showed a higher frequency of axial skeleton
and shoulder OA when compared with hunter-gatherers males
(p<0.02). Conversely, hunter-gatherers displayed a tendency to
present more hip OA (p<0.057).
Conclusions: Contributions of palaeorheumatology help to un-
derstand contemporary diseases. Results of this study support
the notion that anatomic distribution of OA vary among different
groups, and may be the consequence of biomechanical stress
imposed by physical and occupational activities of ancient popu-
lations.
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Purpose: Selective COX-2 inhibitors are prescribed for many
disorders including osteoarthritis (OA). Recent in vitro studies
showed a positive direct effect of celecoxib, one of the selective
COX-2 inhibitors, on human OA cartilage. Such effects are diffi-
cult to verify in a clinical trial because changes in OA cartilage,
degenerative and reparative, are slow and evaluation of articular
cartilage by imaging techniques is still hampered by their limited
sensitivity. Therefore, we used an approach in which the benefits
of in vivo treatment are combined with the benefits of ex vivo
biochemical analyses of the cartilage.
Methods: Patients with knee OA were treated 4 weeks prior to
scheduled knee replacement surgery with celecoxib 2dd200mg,
indomethacin 2dd50mg, or received no treatment. At joint re-
placement surgery, cartilage with underling bone was obtained
from femoral condyles and tibial plateaus. The investigators were
blinded to the patients’ clinical data and medication use. Four
randomly taken samples of each donor were used for histolog-
ical grading of cartilage damage. In addition twenty randomly
taken cartilage samples of each donor were used for biochemi-
cal analysis of proteoglycan (PG) synthesis, -retention, -release,
-content, prostaglandin-E2 (PGE2) production. At least 8 donors
per group were evaluated. Statistical evaluation of the effects of
treatment was performed with an independent-sample T-test. p
values less than or equal to 0,05 were considered statistically
significant The study was conducted according to the declaration
of Helsinki and received ethical approval in all centers.
Results: Average age and gender were comparable between
the different treatment groups. The average histological Mankin
grade of cartilage damage ranged from 4 to 6 in the different
groups and was not statistically significant different between
groups. PGE2 production was diminished for cartilage obtained
from both treated groups when compared to the non treated
patients (all p<0.05).
The non-treated patients (controls) showed a proteoglycan syn-
thesis rate, -retention, -release and -content typical for os-
teoarthritic cartilage. Patients who had used celecoxib showed a
statistically significant higher proteoglycan synthesis compared
to the controls (p<0.03) and a tendency towards a higher syn-
thesis compared to the indomethacin group (p<0.09). The in-
domethacin treated group did not differ from the controls.
This increased proteoglycan synthesis was accompanied by a
better retention of the newly formed proteoglycans; celecoxib
had a diminished release of newly formed PGs compared to the
untreated controls (p<0.01) whereas indomethacin showed no
difference compared to controls.
Also for the total release of proteoglycans, the newly formed
and the resident ones, significant lower values were found for
celecoxib (p<0.01) treated patients compared to the non-treated
controls. Indomethacin treatment showed a tendency towards
a lower total proteoglycan release (p<0.10)Most interestingly,
a treatment period of 4 weeks resulted even in a significant
increase in proteoglycan content in the celecoxib compared to
the controls (p<0.05) and compared to the indomethacin group
(p<0.03). The indomethacin group showed even a tendency to-
wards a lower content compared to the control patients (p<0.14).
Conclusions: Using this novel approach we were able to demon-
strate an in vivo generated beneficial effect of celecoxib, in con-
trast to indomethacin, on OA cartilage proteoglycan turnover.
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Purpose: To assess patients’ satisfaction after knee arthroscopy
for degenerative knee disease, Osteoarthritis (OA).
Methods: – In June 2005 a postal questionnaire was sent to
141 consecutive patients who underwent knee arthroscopy for
osteoarthritis and had washout with or without debridment in
order to assess their subjective satisfaction after the proce-
dure.
– All these arthroscopies were performed in one theatre under
the care of two orthopaedic consultants during the previous two
years.
– The patients were asked to score their preoperative pain on a
1-10 scale.
– Satisfaction assessment was based on a simple core question;
how do they consider their knees at the time of the questionnaire
pain wise and function wise (Same or worse coded unsatisfied
and better coded satisfied).
– Then their notes were reviewed to assess any preoperative
mechanical symptoms (Clicking, locking or giving way), associ-
ated element of trauma, the degree of osteoarthritis they had at
the time of arthroscopy, the immediate post operative recovery
period and the outpatient clinic follow up records.
– These patients were divided into two groups,
A – with no preoperative mechanical symptoms
B – with preoperative mechanical symptoms
Results: – Out of the 141 patients a total of 107 (75.5%)
returned the fully completed questionnaire. Of these, 8 (5.7%)
were excluded because of associated history of trauma and
7(5%) were excluded because of insufficient information or their
notes were not available.
– The average follow up was 13 months (Range 2-24 months).
– The age, sex distribution, preoperative pain score (A=7.6
versus B=8) and the degree of OA (grade 1-3) in both groups
were comparable.
– Patients satisfaction was:
Group A: 32 (74.5%) satisfied, 11(26%) unsatisfied
Group B: 22 (44.9%) satisfied, 27(55%) unsatisfied
With a P value of 0.0057
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Conclusions: – Patients with OA of the knee which is associated
with mechanical symptoms are more likely to achieve subjective
improvement after knee arthroscopy.
– Knee arthroscopy for OA may be reserved only for patients
with preoperative mechanical symptoms.
– More prospective randomised placebo-controlled studies com-
paring both groups are required.
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Purpose: To study the association of socio-demographic and
comorbidity factors with functional limitation in veterans with
osteoarthritis.
Methods: We mailed a survey to all veterans receiving health
care at Upper Midwest Veterans Affairs (VA) Network with an
in- or out-patient encounter between 10/1/96 and 3/31/98. The
survey included Short-Form 36 for veterans (SF36V, a validated
version of SF-36) and questions related to functional limitation
as measured by limitation of six Activities of Daily Living (ADLs;
bathing, dressing, eating, transfer from chair, walking, and toi-
leting), demographics and current smoking status. Patients with
osteoarthritis were identified by the presence of International
Classification of Diseases (ICD)-9 code (715.xx) for diagnosis for
osteoarthritis in VA databases. In- and out-patient health care
utilization (in post-survey year) and comorbidity data using ICD-9
codes were also obtained.
The main predictors of interest were socio-demographic and
comorbidity characteristics. The outcomes of interest were: mod-
erate (1-2 ADLs) or severe ADL (≥3 ADLs) limitation (no ADL
as reference category); any inpatient visit (none as reference
category); and being in the highest quartile of outpatient visits
(other quartiles as reference category). Unadjusted estimates
using t-test and chi-square tests and adjusted odds ratios using
multivariable logistic regression analyses were obtained.
Results: The survey response rate was 58% (40,508/70,334).
7,342 (10%) had an ICD-9 code for osteoarthritis. The mean age
(±standard deviation) was 67±13 years, 96% were men, 95%
were Caucasian. Data on ADL limitation was available for 4,796
subjects (65%). ADL limitation was absent in 25%, moderate in
41% and severe in 34%.
Employment status, marital status and COPD/asthma were as-
P345 – Table 1. Association of Comorbidity and Demographic Factors with Functional Status and Utilization
Moderate ADL Limitation Severe ADL Limitation Inpatient Utilization Outpatient Utilization
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Age (in years) 1 (1.0, 1.0) 0.52 1.0 (1.0, 1.0) 0.46 1.0 (1.0, 1.0) 0.001 1.0 (1.0, 1.0) 0.014
Education 0.11 0.04 0.9 0.002
<8th grade 1.3 (1.0, 1.7) 1.2 (1.0, 1.6) 1.2 (1.0, 1.6) 1.0 (0.8, 1.2) 0.7 (0.5, 0.8)
Some high school 1.1 (0.8, 1.4) 1.0 (0.7, 1.3) 1.0 (0.7, 1.3) 0.9 (0.7, 1.1) 1.0 (0.7, 1.2)
High school Graduate 1.0 (0.8, 1.2) 0.9 (0.7, 1.1) 0.9 (0.7, 1.1) 1.0 (0.8, 1.2) 0.8 (0.7, 1.0)
Employment status 0.015 <0.001 0.026 <0.001
Unemployed 1.5 (1.1, 1.9) 2.3 (1.7, 3.0) 2.3 (1.7, 3.0) 1.4 (1.1, 1.8) 1.5 (1.2, 2.0)
Retired 1.2 (1.0, 1.5) 1.3 (1.0, 1.6) 1.3 (1.0, 1.6) 1.4 (1.1, 1.7) 1.3 (1.1, 1.6)
Unknown 1.7 (1.0, 3.0) 1.9 (1.1, 3.3) 1.9 (1.1, 3.3) 1.4 (0.8, 2.4) 0.8 (0.5, 1.3)
Not married 0.8 (0.7, 1.0) 0.04 0.9 (0.8, 1.1) 0.45 1.5 (1.3, 1.8) <0.001 1.1 (1.0, 1.3) 0.12
Male gender 1.2 (0.9, 1.6) 0.26 1.8 (1.2, 2.7) 0.006 0.9 (0.6, 1.3) 0.44 1.1 (0.7, 1.5) 0.72
Current smoker 1.1 (0.9, 1.3) 0.46 1.2 (0.9, 1.5) 0.17 1.1 (0.9, 1.3) 0.50 0.9 (0.7, 1.1) 0.25
COPD/asthma 1.3 (1.1, 1.6) 0.012 1.6 (1.3, 2.0) <0.001 1.8 (1.5, 2.1) <0.001 1.6 (1.3, 1.9) <0.001
Depression 1.0 (0.7, 1.2) 0.76 1.6 (1.3, 2.1) <0.001 1.9 (1.5, 2.3) <0.001 3.2 (2.6, 4.1) <0.001
Diabetes 1.2 (0.9, 1.4) 0.15 1.4 (1.1, 1.7) 0.005 1.2 (1.0, 1.4) 0.07 1.9 (1.6, 2.3) <0.001
Hypertension 1.1 (0.9, 1.3) 0.25 1.0 (0.8, 1.1) 0.67 1.2 (1.0, 1.4) 0.021 1.2 (1.0, 1.4) 0.015
Heart Disease 1.1 (0.9, 1.4) 0.27 1.1 (0.9, 1.4) 0.27 1.5 (1.2, 1.8) <0.001 1.6 (1.3, 1.9) <0.001
sociated with moderate ADL limitation, while COPD/asthma, de-
pression, diabetes, gender and education were associated with
severe ADL limitation (Table 1).
Age, employment status, marital status, COPD/asthma, depres-
sion, hypertension or heart disease were associated with inpa-
tient use. Age, employment status, education level, and all five
comorbidities were associated with higher outpatient use (Table
1).
Race was not significantly associated with any outcome
Reference categories: Education - College & beyond; Employ-
ment - employed; Marital - married: gender - female
Conclusions: Various comorbidity and demographic factors are
associated with functional status and health care utilization in
patients with osteoarthritis. It is conceivable that better manage-
ment of comorbidities in these patients may improve functional
status and decrease utilization.
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Purpose: To compare the efficacy and safety of Nimesulide ER
200 mg vs. Diclofenac SR 100 mg in patients with osteoarthritis
knee.
Methods: 262 patients aged > 45 years diagnosed to have
osteoarthritis (OA) of knee were randomized (1:1) in this mul-
ticentric study across India. Peptic ulcer disease; compromised
renal/hepatic/cardiovascular function; hematological disease or
bleeding disorders; history of allergy or hypersensitivity to
NSAIDs; pregnancy and lactation were regarded as exclusion.
Patients were allocated to receive either Willgo® (n = 131) or
Voveran SR® (n = 131) tablet as per computer generated ran-
domization once daily for a study treatment period of 30 days.
Protocol assessment visits were on days 15 and 30. Primary effi-
cacy endpoint was evaluated using VAS (Visual Analogue Scale)
of 10 cm for pain at baseline, day 1 (multiple time points), day 15
